EQUITY RESEARCH MEMO

DataHow

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

DataHow is a Swiss AI/ML company founded in 2017 that specializes in digital solutions for bioprocess development. Its core platform, DataHowLab, is a cloud-based system employing hybrid AI models and transfer learning to optimize bioprocess design and experimentation. The platform helps scientists accelerate development, increase yields, and enhance robustness in biopharmaceutical manufacturing. By leveraging AI to reduce trial-and-error, DataHow aims to address the growing need for efficiency and cost reduction in bioprocessing. As the biopharma industry increasingly adopts digitalization, DataHow is well-positioned to provide critical tools for process optimization. The company's focus on a niche yet high-impact area, combined with its innovative technology, suggests strong potential for growth and adoption.

Upcoming Catalysts (preview)

  • Q3 2026Series A or B Funding Round70% success
  • Q4 2026Strategic Partnership with Major Biopharma Company50% success
  • Q2 2026Major Product Update or New Module Launch80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)